Market revenue in 2022 | USD 5.3 million |
Market revenue in 2030 | USD 13.3 million |
Growth rate | 12.2% (CAGR from 2022 to 2030) |
Largest segment | Stem cells |
Fastest growing segment | Other Products |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Stem cells, Other Products |
Key market players worldwide | Boehringer Ingelheim, Zoetis Inc Class A, Dechra Pharmaceuticals, Integra Lifesciences Holdings Corp, Ardent Health Services, Vetherapy, VET-STEM INC., Enso Discoveries, Animal Cell Therapies |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary regenerative medicine market will help companies and investors design strategic landscapes.
Stem cells was the largest segment with a revenue share of 52.83% in 2022. Horizon Databook has segmented the Japan veterinary regenerative medicine market based on stem cells, other products covering the revenue growth of each sub-segment from 2018 to 2030.
A team of Japanese researchers created a novel technique to stimulate the production of stem cells from dog blood samples. The researchers wanted to develop regenerative therapies in veterinary medicine with this technology. This indicates that in the near future, veterinary professionals may be able to cure diseases in dogs that were once believed to be incurable.
To isolate Induced Pluripotent Stem Cells iPSCs from canine blood samples, a research team from Japan has been working under the direction of Associate Professor Shingo Hatoya from Osaka Prefecture University. A developed (or differentiated) cell can be programmed to become an iPSC by putting certain genes into it. These genes produce transcription factors, which are proteins that cause differentiated stem cells to transform into pluripotent stem cells with the capacity to differentiate into diverse cell types.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan veterinary regenerative medicine market , including forecasts for subscribers. This country databook contains high-level insights into Japan veterinary regenerative medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account